| Hans-Günter Meyer-Thompson | Amphetamine
The Lancet Psychiatry: ADHD medications: Of all available drugs, methylphenidate should be first option for short-term treatment in children
The Lancet Psychiatry: ADHD medications: Of all available drugs, methylphenidate should be first option for short-term treatment in children
Study includes 133 double-blind randomised controlled trials with data from more than 14,000 children and adolescents and 10,000 adults.
The authors say that environment modifications and non-pharmacological interventions should be considered first, but drugs can play an important role in treating ADHD. The study provides information for clinicians on the relative effectiveness and safety of various ADHD drugs. (The Lancet, 07.08.2018)
https://www.eurekalert.org/pub_releases/2018-08/tl-tlp080618.php